ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "corticosteroids"

  • Abstract Number: 273 • 2019 ACR/ARP Annual Meeting

    Bone Health in Lupus: Findings from the Southern California Lupus Registry

    Vaneet Sandhu, MBBS1 and Sara Johnson 2, 1Loma Linda University, Loma Linda, CA, 2St George's University, Loma Linda, CA

    Background/Purpose: The association of vitamin D deficiency with SLE is well established. While disease activity can itself cause pathologic bone remodeling and reduced vitamin D,…
  • Abstract Number: 858 • 2019 ACR/ARP Annual Meeting

    Adverse Events of Special Interest, SLE Medication Utilization, Hospitalizations, and Organ Damage: Results from a Phase 4, Randomized, Double-Blind, Placebo-Controlled, 52-week Study of Belimumab in Adults with Active, Autoantibody-Positive SLE

    Saira Sheikh1, Morton Scheinberg 2, Cheng-Chung Wei 3, Dana Tegzova 4, William Stohl 5, Ricardo Acayaba de Toledo 6, Tamara Mucenic 7, Mauricio Abello Banfi 8, Kathleen Maksimowicz-McKinnon 9, Carlos Abud-Mendoza 10, Sandra Navarra 11, Mercedes Garcia 12, Ignacio Garcia-De La Torre 13, Josep Ordi Ros 14, Roger Abramino Levy 15, Damon L Bass 15, Jorge Ross Terrés 16, Raj Punwaney 16, Julia Harris 17, Alireza Nami 18, Amy Pierce 19, Kevin Thorneloe 20, Beulah Ji 17 and David Roth 16, 1University of North Carolina, Chapel Hill, NC, 2Centro de Pesquisas Clinicas do Hospital Abreu Sodré, São Paulo, Brazil, 3Chung Shan Medical University, Taichung City, Taiwan (Republic of China), 4Institute of Rheumatology, Prague, Czech Republic, 5University of Southern California Keck School of Medicine, Los Angeles, CA, 6Faculdade de Medicina de São José do Rio Preto, São Paulo, Brazil, 7Hospital Moinhos Angeles de Vento, Porto Alegre, Brazil, 8Centro Integral de Reumatología del Caribe, Barranquilla, Colombia, 9Henry Ford Hospital, Wayne State University, Detroit, MI, 10Hospital Central “Dr Ignacio Morones Prieto”, Unidad Regional de Reumatologia y Osteoporosis, Hospital Central and Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosi, Mexico, 11University of Santo Tomas Hospital, Manila, Philippines, 12Hospital San Martín, La Plata, Argentina, 13Centro de Estudios de Investigación Básica y Clínica, S.C., Guadalajara, Jalisco, Mexico, 14Hospital Vall d'Hebron, Barcelona, Spain, 15GlaxoSmithKline, Collegeville, PA, 16GSK, Collegeville, PA, 17GSK, Uxbridge, Middlesex, United Kingdom, 18Joint Muscle Medical Care and Research Institute, Charlotte, NC, 19ViiV Healthcare, Research Triangle Park, NC, 20GSK, Collegeville, NC

    Background/Purpose: Belimumab (BEL), approved in active, autoantibody-positive SLE, has demonstrated a positive efficacy/safety profile while suggesting potential for steroid sparing and reduced organ damage accrual.…
  • Abstract Number: 1309 • 2019 ACR/ARP Annual Meeting

    Concordance of Baseline Pain Measures (Across Two Reporting Instruments) Influences Treatment Effect: Post Hoc Analysis of a Phase 3 Randomized Controlled Trial of Triamcinolone Acetonide Extended-Release in Patients with Knee Osteoarthritis

    Philip G Conaghan1, Edgar Ross 2, Alan Kivitz 3, Dennis Turk 4, Andrew Spitzer 5, Deryk Jones 6, Ryan Lanier 7, Amy Cinar 8, Joelle Lufkin 8 and Scott Kelley 8, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom, 2Brigham and Women's Hospital, Boston, MA, 3Altoona Center for Clinical Research, Duncansville, PA, 4University of Washington, Seattle, 5Cedars-Sinai Medical Center, Los Angeles, 6Ochsner Sports Medicine Institute, Harahan, GA, 7Analgesic Solutions, Natick, 8Flexion Therapeutics, Burlington

    Background/Purpose: In a Phase 3 randomized controlled study, differing efficacy results were observed when triamcinolone acetonide extended-release (TA-ER) was compared to conventional TA crystalline suspension…
  • Abstract Number: 2068 • 2019 ACR/ARP Annual Meeting

    Body Mass Index and Systemic Corticosteroid Use as Indicators of Disease Burden and Their Influence on the Safety Profile of Certolizumab Pegol Across Indications

    Vivian Bykerk1, Andrew Blauvelt 2, Jeffrey Curtis 3, Cécile Gaujoux-Viala 4, Tore K. Kvien 5, William J. Sandborn 6, Kevin Winthrop 7, Christina Popova 8 and Xavier Mariette 9, 1Hospital for Special Surgery, New York City, NY, 2Oregon Medical Research Center, Portland, OR, USA, Portland, OR, 3University of Alabama at Birmingham, Birmingham, AL, 4Nîmes University Hospital, Nîmes, France, 5Diakonhjemmet Hospital, Oslo, Norway, 6University of California, La Jolla, CA, 7Oregon Health and Science University, Portland, OR, 8UCB Pharma, Brussels, Belgium, 9Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France

    Background/Purpose: Certolizumab pegol (CZP) is an anti-TNF drug approved for rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis (PSO) and Crohn’s disease (CD).…
  • Abstract Number: 2114 • 2019 ACR/ARP Annual Meeting

    Risk Factors for Cytomegalovirus Infection in Patients with Autoimmune Diseases

    Daisuke Kobayashi1, Sayuri Takamura 2, Yoko Wada 3, Takeshi Kuroda 4 and Ichiei Narita 1, 1Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Niigata, Japan, 2Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Japan, 3Niigata Rinko Hospital, Niigata, Niigata, Japan, 4Health administration office, Niigata University, Niigata, Niigata, Japan

    Background/Purpose: Intensive immunosuppressive treatment is often required for patients with autoimmune diseases, and those who are thus treated have a high risk of opportunistic infections.…
  • Abstract Number: 2784 • 2019 ACR/ARP Annual Meeting

    Alterations in Inflammatory, TNF-Superfamily, and IFN-Associated Chemokines Precede Clinical Changes in SLEDAI After Methylprednisolone Treatment of SLE Patients

    Melissa E. Munroe1, Carla J. Guthridge 1, Sarah Kleckner 1, Ly Tran 2, Joel Guthridge 3, Debra J. Zack 4, Judith James 3 and Joan T. Merrill 5, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, 3Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Xencor, Inc., San Diego, CA, 5Okalahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: SLE is typified by a wide spectrum of clinical manifestations and immune dysregulation. Corticosteroids are almost universally effective, but marked by unacceptable side effects.…
  • Abstract Number: 2190 • 2018 ACR/ARHP Annual Meeting

    Means of Collaboration between Ophthalmologists, Rheumatologists and Internists in the Management of Non-Infectious Uveitis: A Nationwide Study

    Magali Pacanowski Fournier1, Antoine Brezin2, Christophe Chiquet Sr.3, David Saadoun4, Jeremie Sellam5, Patrice Cacoub6, Pascal Sève7, Bahram Bodaghi Sr.8 and Laurent Kodjikian Sr.9,10,11, 1medical department, Magali Pacanowski Fournier is employee of AbbVie and own AbbVie stock, Rungis, France, 2Ophtalmology, Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, 3ophtalmology, CHU-Grenoble-Alpes, La Tronche, France, 4Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier, Paris, France, 5AP-HP Saint-Antoine hospital, Service de Rhumatologie, Inserm UMRS_938, Paris, France, 6Internal Medicine Department, University Hospital “Pitié-Salpêtrière”, “Pierre et Marie Curie Paris VI” University, Paris, France, Paris, France, 7Internal medicine, Internal medicine department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France, 8ophtalmology, Hôpital La Pitié-Salpêtrière; Université Sorbonne, paris, France, 9ophtalmology, Chu de La Croix-Rousse, hospices civils de Lyon, Lyon, France, 10université Claude Bernard lyon 1, villeurbanne, France, 11UMR-CNRS 5510 Matéis, villeurbanne, France

    Background/Purpose: When uveitis is believed to be part of an underlying systemic disease or when a systemic treatment is required, a multi-disciplinary approach is usually…
  • Abstract Number: 2191 • 2018 ACR/ARHP Annual Meeting

    Safety of Ultrasound-Guided Injections Using Local Puncture Site Sterility

    Suzan Jaradat1, Maheswari Muruganandam2, Noelle Rolle2, Wilmer Sibbitt Jr.3, William Hayward4, N. Suzanne Emil3, Monthida Fangtham3, Roderick Fields3 and Arthur Bankhurst3, 1Internal Medicine, University of New Mexico Health Sciences Center, ALBUQUERQUE, NM, 2University of New Mexico Health Sciences Center, ALBUQUERQUE, NM, 3Rheumatology, University of New Mexico Health Sciences Center, Albuquerque, NM, 4The Department of Exercise and Sport Sciences, New Mexico Highlands University, Las Vegas, NM

    Background/Purpose:  Ultrasound (US)-guided injections in musculoskeletal medicine typically utilize either local puncture site sterility or conventional surgical sterility. We report on the safety and complications…
  • Abstract Number: 2198 • 2018 ACR/ARHP Annual Meeting

    Evaluation of 18F-Fluorodeoxyglucose PET-CT Score at Baseline on the Therapeutic Response to Prednisone in Polymyalgia Rheumatica: A Retrospective Study

    Nicolas Giraud1, Maxime Sondag2, Aline Charpentier2, Hatem Boulahdour3, Clément Prati4,5, Daniel Wendling6,7 and Frank Verhoeven8, 1Rheumatology, CHU de Besançon, Besançon, France, 2rheumatology, CHU de Besançon, Besancon, France, 3CHU de Besançon, Besançon, France, 4EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche Comté, Besancon, France, 5Rheumatology, University Hospital - Bourgogne Franche Comté University, Besancon, France, 6Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, 7EA 4266, Univ. Bourgogne Franche-Comté, F-25000 Besançon, France, F-25000 Besançon, France, 8EA 4267 PEPITE, Université de Bourgogne Franche Comté, Besançon, France

    Background/Purpose: To evaluate the impact of 18F-fluorodeoxyglucose PET-CT (FDG-PET/CT) score at baseline, on the therapeutic response to prednisone, in patients with polymyalgia rheumatica (PMR). Methods:…
  • Abstract Number: 2390 • 2018 ACR/ARHP Annual Meeting

    Incidence of and Risk Factors for Adrenal Suppression Following Ultrasound-Guided Intra-Articular Corticosteroid Injection with Triamcinolone Acetonide in Juvenile Idiopathic Arthritis

    Katherine K Ngo1, Angelina Bernier1, Melissa E Elder2, Renee F Modica2 and Akaluck Thatayatikom1, 1Pediatrics, University of Florida, Gainesville, FL, 2Department of Pediatrics, University of Florida, Gainesville, FL

    Background/Purpose: Intra-articular corticosteroid injection (IACI) is routinely used in juvenile idiopathic arthritis (JIA) with oligoarticular disease and as adjunct therapy for other types of JIA.…
  • Abstract Number: 2773 • 2018 ACR/ARHP Annual Meeting

    Diagnostic and Therapeutic Management of a Suspected Case of GCA: An Opinion Survey

    Henri Guillet1, Raphaël Porcher2, Alain Saraux3, Loïc Guillevin4, Luc Mouthon4 and Alexis Régent4, 1Département d'aval des urgences, CHU Henri Mondor, Créteil, France, 2Université Paris Descartes Sorbonne Paris, Paris, France, 3Rheumatology, CHU Brest, Brest, France, 4Institut Cochin, INSERM U1016, CNRS UMR 8104, PARIS, France

    Background/Purpose: Giant-cell arteritis (GCA) is the most common vasculitis. Specialists have formulated recommendations on how to manage a patient with a possible diagnosis of GCA.…
  • Abstract Number: 462 • 2018 ACR/ARHP Annual Meeting

    Steroid Use in Pediatric Proliferative Lupus Nephritis

    Nathalie Chalhoub1, Jianghong Deng2, Natasha M. Ruth3, Stacy P. Ardoin4, Mileka Gilbert5, Theresa Hennard6, Linda Hiraki7, Paul T. Jensen8, Andrea M. Knight9, Rebecca Kunder10, Laura Lewandowski11, Siok Hoon Lily Lim12, Angela Merritt13, Sonia Iqbal Savani14, Mary Beth Son15, Emily von Scheven16, Scott E. Wenderfer17 and Hermine I. Brunner6, 1Division of Immunology, Allergy, and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH, 2Division of Rheumatology, Beijing Children’s Hospital and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Rheumatology, Medical University of South Carolina, Charleston, SC, 4Division of Rheumatology, Nationwide Children’s Hospital, Columbus, OH, 5Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, 6Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 8Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 9Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 10Gilead Sciences, Inc, Redwood City, CA, 11NIAMS/NIH, Bethesda, MD, 12Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, Canada, 13Pediatric Rheumatology, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 14Medical University of South Carolina, Charleston, SC, 15Boston Children's Hospital, Harvard Medical School, Brookline, MA, 16Pediatric Rheumatology, University of California San Francisco, San Francisco, CA, 17Pediatrics-Renal, Baylor College of Medicine, Houston, TX

    Background/Purpose: Corticosteroids (CS) are the mainstay of childhood-onset lupus (cSLE) and proliferative lupus nephritis (LN) therapy. However, there are no widely accepted CS dosing regimens…
  • Abstract Number: 478 • 2018 ACR/ARHP Annual Meeting

    Evidence Based Recommendations for Corticosteroid Tapering/Discontinuation in New Onset Juvenile Dermatomyositis Patients: Results from the Paediatric Rheumatology International Trials Organisation

    Gabriella Giancane1, Claudio Lavarello2, Angela Pistorio2, Francesco Zulian2, Bo Magnusson3, Tadej Avcin2, Fabrizia Corona2, Valeria Gerloni2, Serena Pastore2, Roberto Marini2, Silvana Martino2, Anne Pagnier4, Michel Rodiere2, Christine Soler2, Valda Stanevicha2, Rebecca ten Cate2, Yosef Uziel2, Jelena Vojinovic2, Elena Fueri2, Angelo Ravelli5, Alberto Martini6 and Nicola Ruperto7, 1Clinica Pediatrica - Reumatologia, Istituto Giannina Gaslini, Genoa, Italy, 2Istituto Giannina Gaslini - Clinica Pediatrica e Reumatologia - PRINTO, Genoa, Italy, 3Karolinska University Hospital, Stockholm, Sweden, 4Istituto Giannina Gaslini - Clinica Pediatrica e Reumatologia - PRINTO, Genova, Italy, 5Clinica Pediatrica - Reumatologia, Istituto Giannina Gaslini, Genova, Italy, 6Universita di Genova Pediatria II, Genova, Italy, 7Istituto Giannina Gaslini - Clinica Pediatrica e Reumatologia, Genoa, Italy

    Background/Purpose: At present no clear evidence based guidelines exist to standardize the tapering and discontinuation of corticosteroids (CS) in juvenile dermatomyositis (JDM). Aim of our…
  • Abstract Number: 621 • 2018 ACR/ARHP Annual Meeting

    Practical Optimization of Methotrexate Dose Improves Disease Control of Rheumatoid Arthritis Despite Reduction or Discontinuation of Oral Glucocorticoids

    Shintaro Hirata1, Kei Araki1, Hiroki Kohno1, Kazutoshi Yukawa1, Tadahiro Tokunaga1, Tatsuomi Kuranobu1, Katsuhiro Oi1, Yusuke Yoshida1, Tomohiro Sugimoto1, Keisuke Oda1,2, Takaki Nojima1,3 and Eiji Sugiyama1, 1Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 2Hiroshima Clinic, Hiroshima, Japan, 3Nojima Internal Medicine Clinic, Hiroshima, Japan

    Background/Purpose: Short-term glucocorticoids (GCs) along with methotrexate (MTX) has been recommended for newly onset patients with rheumatoid arthritis (RA) in EULAR recommendation 2016. However, it…
  • Abstract Number: 712 • 2018 ACR/ARHP Annual Meeting

    Higher Prednisolone Dose during Treatment of Tuberculosis Correlates with Mortality during Tuberculosis Treatment in Systemic Lupus Erythematosus Patients: A Retrospective Cohort Study

    Chiao-Feng Cheng, Cheng-Hsun Lu, Song-Chou Hsieh and Ko-Jen Li, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

    Background/Purpose: Tuberculosis (TB) has complex interplay with systemic lupus erythematosus (SLE). In addition, SLE, corticosteroid, and immunosuppressants are associated with TB infection. However, the prognostic…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.